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Abstract 
Streptococcus pyogenes is a human-specific pathogen that uses a variety of adhesion 
molecules in order to initiate pharyngeal infection and maintain colonization. One genomic 
locus that is believed to contribute to adherence is the fibronectin-binding, collagen-
binding, T-antigen (FCT) region, primarily due to the inclusion of genes that encode for a 
pilus (tee18.1), collagen-binding protein (cpa), and fibronectin-binding protein (prtF2). 
The precise role of these genes and the FCT region as a whole, however, have yet to be 
elucidated within the context of pharyngeal infection. In this study, we utilize the M18 
serotype S. pyogenes strain MGAS8232 to demonstrate that the presence of the FCT region 
is critical in binding collagen type IV and fibronectin, and is additionally required for 
invasion into human pharyngeal cells, despite not impacting adherence to these cells. 
Furthermore, using a murine nasopharyngeal infection model, we determine that only cpa 
is expressed in vivo, and that removal of the FCT region does not impede the bacteria’s 
ability to establish infection. Overall, this study demonstrates that the FCT region is not 
involved during acute nasopharyngeal infection by S. pyogenes MGAS8232 but may 
contribute to the pathogenic life cycle through other mechanisms. 
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Lay Summary 
Streptococcus pyogenes is a human-specific bacterium that can cause a multitude of 
diseases with outcomes that range from mild to fatal. Streptococcal pharyngitis, or more 
commonly known as ‘strep throat’, is one of these diseases and affects more than 600 
million people annually. Although this disease can be self-limiting or treated with 
antibiotics, the persistence or recurrence of pharyngeal infection can result in more harmful 
complications, such as rheumatic heart disease, which can be fatal in severe cases. As such, 
it is critical to understand the initial infectious state of S. pyogenes. A crucial step during 
its pharyngeal infection is the adhesion to host tissue, which occurs through a variety of 
molecules that are often attached to the bacteria’s surface. One particular genomic locus 
implicated in adhesion is the fibronectin-binding, collagen-binding, T-antigen (FCT) 
region, which notably encodes a pilus structure (tee18.1), a collagen-binding protein (cpa), 
and a fibronectin-binding protein (prtF2). In this study we remove this region from the 
bacteria’s genome and assess the adherence capabilities of this mutant to several 
components found at the site of infection, including collagen type IV, fibronectin, and 
human pharyngeal cells and demonstrated that the FCT region is required to bind collagen 
type IV and fibronectin, but not the pharyngeal cells. Interestingly, we discovered that the 
ability to invade pharyngeal cells, which may lead to more detrimental diseases, is entirely 
reliant on the FCT region. In addition, we quantify the expression of tee18.1, cpa, and 
prtF2 in mice that have been infected with S. pyogenes and determined that only cpa was 
expressed. Furthermore, using the same mouse nasopharyngeal infection model, we 
demonstrated that removal of the FCT region does not impede the bacteria’s ability to 
establish infection. This study demonstrates that the FCT region is not involved during 
acute nasopharyngeal infection by S. pyogenes but may contribute to the pathogenic life 
cycle through other mechanisms. Overall, comprehensively evaluating the life cycle of S. 
pyogenes can provide insight on how to combat this globally-prevalent pathogen. 
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1.1. Streptococcus pyogenes 
Streptococcus pyogenes, sometimes referred to as the Group A Streptococcus, is a Gram-
positive, aerotolerant anaerobe with human-specific tropism. This bacterium typically 
grows in chains of varying lengths and exhibits the characteristic β-hemolysis of red blood 
cells. Classification of β-hemolytic streptococci is based on the expression of cell wall 
polysaccharides and subsequent categorization into Lancefield antigen groups A, B, C, D, 
etc., wherein S. pyogenes is the only species to be classified as a Group A Streptococcus 
(1). Isolates and strains of this species are further classified through examination of the 
variable (~20) Lancefield T-antigen, as well as the variable (>230) M protein (2). The S. 
pyogenes genome consists of a ~1.8 Mbp circular chromosome with a G+C content of 
~38.5%. Many genes encoded within S. pyogenes, most notably virulence factors, display 
great variability between strains, which can be attributed to the inclusion of exogenous 
genetic elements such as phage, and phage-like insertions, as well as genetic mobility 
through horizontal gene transfer (3–5). Although S. pyogenes can colonize the skin and 
mucosal surfaces asymptomatically, it can also act as an opportunistic pathogen and cause 
a multitude of diseases with clinical manifestations ranging from mild to fatal (6, 7). Some 
of these diseases may be self-limiting such as pharyngitis or impetigo, while others can be 
more severe such as necrotising fasciitis or toxic shock syndrome. Additionally, S. 
pyogenes has been linked to various post-infection sequelae such as glomerulonephritis, or 
acute rheumatic fever (ARF) and the subsequent development of rheumatic heart disease 
(RHD) (8). Accordingly, S. pyogenes represents a significant affliction on human health. 
 
1.2. Streptococcal infection and the global burden of disease 
S. pyogenes, and the various diseases it can cause, are a major source of worldwide 
morbidity and mortality. Population studies have estimated that the annual incidence of 
acute pharyngitis and the superficial skin infection impetigo are at least 616 million and 
140 million cases, respectively (9, 10). Symptoms of streptococcal pharyngitis include 
fever, enlarged lymph nodes, and inflammation of the pharynx with exudations on the 
tonsil (11, 12). Although the majority of S. pyogenes infections can be self-limiting or 
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treated efficiently with β-lactam antibiotics, the persistence of the bacteria, or invasion past 
the epithelial barrier, can result in more severe diseases (10, 12). 
  
Invasive streptococcal disease is characterized by the bacteria entering a normally-sterile 
site, including the bloodstream, fascia, muscle, or lungs. Infection in these areas can then 
lead to potentially fatal diseases, including bacteremia, streptococcal toxic shock syndrome 
(STSS), or necrotising fasciitis. Unfortunately, epidemiological data suggests that the 
prevalence of invasive streptococcal disease is increasing (9, 10). STSS, which is the most 
dangerous form of invasive streptococcal disease, is believed to be mediated by S. 
pyogenes-produced toxins (13). Early symptoms of STSS are often non-specific but the 
progression of this disease is associated with early muscle pain or pharyngitis, followed by 
the onset of fever and hypotension, which may ultimately lead to multiple organ failure, 
and in ~40% of cases, death (14–16).  Treatment of STSS primarily includes supportive 
therapy, antibiotic treatment with a focus on penicillin and clindamycin, and may include 
the use of polyclonal intravenous immunoglobulins (IVIG). In recent years, however, an 
increasing number of studies find that despite the reduction in organ failure and other 
clinical manifestations, the use of IVIG results in patient survival rates that are statistically 
no different than the control groups (17–19). Necrotizing fasciitis, otherwise known as 
“flesh-eating disease,” is characterized by necrosis of the subcutaneous tissue and fascia, 
and presents with symptoms including severe pain, fever, and necrotic tissue with edema 
(20, 21). The rapid spread of necrotising fasciitis makes it crucial to remove the necrotic 
tissue and treat the affected area(s) with an antibiotic regimen similar to STSS (20).  
 
Infection with S. pyogenes can also induce post-infection sequalae such as ARF or post-
streptococcal glomerulonephritis. ARF is a delayed consequence that may occur due to the 
persistence or recurrence of untreated S. pyogenes pharyngeal infection, and can result in 
damage to the joints, brain, and heart (12, 22). The most substantial manifestation of ARF 
is repeated immune-mediated damage to the heart valves, which can progress into RHD 
(23). Globally, there have been estimated to be at least 18.1 million cases of severe S. 
pyogenes infection annually, with 517,000 of these cases resulting in death; the greatest 
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contributor to mortality is RHD, which results in 345,000 deaths annually, with an 
additional 116,000 deaths being caused by RHD-mediated complications (9, 10).  
 
The precise incidence of diseases caused by S. pyogenes, however, is likely 
underrepresented given that the bacteria affects low-resource settings significantly more 
than high-income areas. Aside from the biological and geographical factors influencing 
prevalence, the burden of S. pyogenes can be greatly accredited to socioeconomic factors 
such as poor sanitation standards and lack of access to healthcare. Coupled with the absence 
of efficient data managing systems and epidemiological models, these circumstances 
obscure the actual statistical prevalence, incidence, and mortality of S. pyogenes infection 
in areas where the impact of disease is greatest. The global burden of this organism has 
caused the World Health Organization to categorize S. pyogenes as the ninth leading cause 
of human mortality with respect to infectious diseases, thus highlighting the importance of 
understanding the pathogenesis of this organism (10, 24).  
 
1.3. Asymptomatic Carriage 
The asymptomatic carriage of S. pyogenes is characterized by the presence of bacteria 
without any signs or symptoms indicative of infection. Indeed, the predominant form of 
interaction between S. pyogenes and humans is asymptomatic carriage, in which 
persistence in the pharynx is considered the primary reservoir for a variety of S. pyogenes 
strains (25). In addition, S. pyogenes is able to asymptomatically colonize the skin, vagina, 
and rectum, but does so to a lesser degree (26). Concerning asymptomatic carriage, 
detection of S. pyogenes is typically a two-step process that involves a posterior pharynx 
swab as well as serological testing (27). One meta-analysis found that 37% of children with 
sore throat presented signs of pharyngitis, and 12% of the children studied were deemed 
asymptomatic carriers (28). Additionally, it has been documented that approximately 25% 
of household cohabitants of children with streptococcal pharyngitis were positive for S. 
pyogenes while remaining asymptomatic, therefore suggesting that carriage is linked to 
living situations within a closed environment (29). Nevertheless, asymptomatic carriers of 
S. pyogenes do not seem to be capable of efficiently transmitting the bacteria. This may be 
due to several reasons, such as lack of respiratory secretions and symptoms that would 
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typically help the spread of bacteria, as well as the reduced density of S. pyogenes in the 
pharynx of carriers compared to symptomatic individuals (30, 31). Although it is predicted 
that host factors and bacterial determinants that assist immune evasion may prompt the 
development of asymptomatic carriage, the majority of studies detailing this highly 
common state are epidemiological in nature (27). As such, the exact molecular mechanisms 
that contribute to asymptomatic carriage of S. pyogenes remains unclear.  
 
1.4. Streptococcus pyogenes secreted virulence factors 
S. pyogenes employs a multitude of secreted virulence factors to mediate the start of 
infection as well as subsequent colonization of the host. This vast array of factors includes: 
DNAses, cytolytic toxins, proteases, bacteriocins, complement inhibitors, as well as 
mitogenic toxins known as superantigens. Although there are many more secreted 
virulence factors that  contribute to the pathogenesis of S. pyogenes within its infectious 
niche, superantigens are of particular relevance to this project (32, 33). 
 
1.4.1. Superantigens 
Superantigens refer to a family of mitogenic toxins produced by a limited number of 
microorganisms. Most notably, these compounds are produced by S. pyogenes and 
Staphylococcus aureus, but are also expressed by other bacteria such as Yersinia 
pseudotuberculosis and Mycoplasma arthritidis, as well as viruses including the mouse 
mammary tumour virus (34–37). These unique toxins are characterized by their ability to 
bridge the connection between the human leukocyte antigen (HLA) major 
histocompatibility complex (MHC) class II molecules on antigen-presenting cells and the 
variable-β (Vβ) chain of T cell receptors on T cells; peculiarly, superantigens can undergo 
this binding without a specific singular peptide (38). Depending on the particular sequence 
and architecture of each superantigen, it preferentially interacts with a subset of Vβ-specific 
T cells and certain MHC class II molecule haplotypes (39, 40). Because superantigens are 
able to circumvent the peptide-specific nature of immunity, they are able to activate up to 
20% of a host’s T cell population, which is in stark contrast to the 10-3–10-4% of naïve T 
cells that are activated during classical antigen-specific immunity (37, 40).  
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Historically, streptococcal superantigens have been implicated in numerous diseases 
including scarlet fever and STSS, yet their evolutionary function has yet to be solidified. 
Previous studies from our laboratory have postulated that superantigens are crucial for the 
initiation of infection by S. pyogenes (41, 42). In order to substantiate this concept, we 
developed a novel murine nasopharyngeal infection model that bypasses the human-
specific tropism of S. pyogenes by utilizing mice that express HLA MHC class II molecules 
(alleles DR4/DQ8) (41, 43). Using this model, we verified that the streptococcal pyrogenic 
exotoxin A (SpeA) was necessary for the mice to consistently develop a robust acute 
infection (41). Moreover, we demonstrated that vaccination with a toxoid version of SpeA 
resulted in antibody-mediated protection thereby preventing S. pyogenes infection upon 
bacterial challenge (43). It therefore stands that the relationship SpeA has with the host 
extends beyond causing severe diseases, and instead may primarily function to initiate 
acute infection and persist in the nasopharynx. Additionally, because S. pyogenes encodes 
numerous superantigens, this role in pathogenesis may be preserved through redundancy.  
 
1.5. Streptococcus pyogenes surface adherence molecules 
In addition to the arsenal of secreted factors, S. pyogenes also utilizes a variety of surface-
linked adhesion molecules in order to avoid bacterial clearance from host-derived 
mechanical, cellular, and humoral defenses. Some of these predicted factors include 
lipoteichoic acid (LTA), M protein, the hyaluronic acid capsule, pili, collagen-binding 
proteins, and fibronectin-binding proteins (FBPs) (44–47). Adhesion in S. pyogenes has 
been hypothesized to be a two-step process, in which LTA initially mediates weak 
hydrophobic interactions with host cells proceeded by high affinity interactions between 
specific S. pyogenes adhesion molecules and their cognate receptors (48). Interestingly, the 
expression of these adhesion factors differs dramatically between S. pyogenes strains, and 
is thought to be a significant contributor to stain-specific tissue tropism (25, 49). 
 
1.5.1. M protein 
The M protein, encoded by the emm gene, is a major surface component of S. pyogenes, 
and remains one of the most studied virulence factors from this bacterium. This protein is 
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attached to the bacterial cell wall through a conserved LPXTG motif at its C-terminus, 
while its N-terminus encodes a hypervariable region exposed to the extracellular 
environment (2, 50). The genetic variability in its N-terminus has resulted in more than 230 
emm types, which serve as the basis for S. pyogenes serotype (2, 51, 52).  
 
This multifunctional protein is primarily known for its function in antiphagocytic immune 
evasion. It accomplishes this by attaching to various host proteins to prevent the activation 
and deposition of complement factors on the bacterial surface (53–55). The molecular 
diversity within its hypervariable N-terminus also presents the opportunity to bind a 
plethora of human host cells and receptors (44, 54). Studies have demonstrated that M types 
may play a role in adhesion to various tissue types. For example M1, M5, and M6 serotypes 
have been shown to adhere HEp-2 cells and the pharyngeal cell line Detroit-562, but, along 
with M24 and M3, are not responsible for mediating adhesion to buccal epithelial cells 
(56–58). Moreover, M proteins from various serotypes were found to bind the keratinocyte 
membrane cofactor protein 46 (CD46); the M6, M12, and M18 proteins, however, 
displayed weak or no binding to CD46, indicating that this protein is not a universal target 
of the M protein (59, 60). Therefore, the diverse binding capabilities of different M proteins 
constitute the potential for a range of serotype-specific host-pathogen interactions. 
 
The M protein has also been potentially implicated in tissue tropism and disease 
manifestations (61, 62). M proteins are grouped together based on their architecture, as 
well as their inclusion or exclusion of certain domains. emm groups A-C are 
overwhelmingly obtained from pharyngeal isolates, whereas group D are strongly 
associated with skin infections. Dissimilarly, strains that are included within group E are 
considered generalists, and have been obtained from both pharyngeal and skin isolates (45, 
62–64). 
 
1.5.2. Hyaluronic acid capsule 
The majority of S. pyogenes strains produce a high molecular weight polysaccharide 
capsule composed of hyaluronic acid. Notably, hyaluronic acid is a major component of 
the human extracellular matrix (ECM), thereby making the capsule immunogenically inert 
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(7, 65). Although the precise function of the capsule is still debated, multiple studies have 
implicated a role in adhesion through its interaction with the host ligand CD44, which is 
involved in adherence to pharyngeal tissue by host cells (66–68).  
 
Of importance, the regulation of the hyaluronic acid capsule seems to be heavily dependant 
on the nature of infection. For instance, it has been demonstrated in baboons that 1 hour 
post-inoculation in the pharynx, capsule gene expression is upregulated, suggesting a role 
during the early stages of infection (69). Moreover, the hyperencapsulated M18 serotype 
has been shown to persist longer in the nasopharynx of mice compared to a mutant strain 
that had reduced capsular expression (70). Contrarily, the hyperencapsulation of the 
virulent M1T1 strain is hypothesized to diminish adhesion to human pharyngeal cells due 
to its long hyaluronic acid chains physically obstructing other adhesion molecules and their 
access to host ligands. (71). By producing a molecule identical to a compound found in its 
host, S. pyogenes is able to utilise a possible infection or colonization factor while 
simultaneously evading the host immune response.  
 
1.5.3. The fibronectin-binding, collagen-binding, T-antigen 
region 
In addition to standalone components that mediate adhesion, S. pyogenes also encodes a 
variable genomic locus, known as the Fibronectin-binding, Collagen-binding, T-antigen 
(FCT) region. Due to the gene composition of this locus, it is hypothesized to play an 
important role in the adhesion of S. pyogenes to ECM proteins and various epithelial cells. 
To date, there have been 9 distinct variants of the FCT region identified amongst the many 
S. pyogenes strains, with further strain-specific sequence variation also reported within the 
encoded genes (49, 72). Although the origin of this ~9‒16 kb locus is presently unknown, 
it is believed to have evolved its genetic organization and allelic variability through 
intergenomic homologous recombination events, as well as potential transposase activity 
(72–74). Flanked by two highly conserved genes, the general constituents of this locus are 
detailed in Table 1. 
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Table 1. Genes encoded within the different FCT region variants 
Gene Description Presence of gene in  
FCT region variants a 
rofA or nra Standalone regulator All FCT variants 
prtF1 Fibronectin-binding protein F1 FCT-1, FCT-4, FCT-5, FCT-7, 
FCT-8, FCT-9 
cpa/fctX Ancillary pilus protein 1/ 
collagen-binding protein 
FCT-1, FCT-2, FCT-3, FCT-4, 
FCT-5, FCT-6, FCT-8 
lepA/sipA1/sipA2 Putative signal peptidase FCT-2, FCT-3, FCT-4, FCT-7, 
FCT-8 
tee/fctA Major pilus subunit/T-antigen All FCT variants 
srtB/srtC2 Locus-specific sortase All FCT variants 
fctB Ancillary pilus protein 2/   
pilus anchoring subunit 
FCT-2, FCT-3, FCT-4, FCT-5, 
FCT-6, FCT-7, FCT-8, FCT-9 
msmR Standalone regulator; only 
present in strains with prtF2 
FCT-3, FCT-4, FCT-7, FCT-8 
prtF2 Fibronectin-binding protein F2 FCT-3, FCT-4, FCT-5, FCT-7, 
FCT-8 
inv/rev Putative transposable element FCT-1, FCT-2, FCT-5, FCT-9 
a The presence of certain constituents within the 9 distinct FCT variants was organized in this 
table based on information from various sources (49, 75–79). 
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1.5.3.1. Pili 
The most notable component of the FCT region is the pilus, which is a polymer composed 
of a major pilus subunit, as well as one or two ancillary proteins. Specifically, ancillary 
protein 1 is a collagen-binding protein that is usually attached to the pilus tip, and ancillary 
protein 2 anchors the pilus to the cell wall (80, 81).  Interestingly, in some cases, the major 
pilus subunits are the T-antigens used in serological classification implying that distinct 
FCT regions encode antigenically distinct pili (47, 82, 83). These subunits are comprised 
of two immunoglobulin-like domains, which attach to adjacent subunits via a covalent 
isopeptide bond (84). After numerous rounds of head-to-tail polymerization, the ~2nm 
wide and >1µm long pilus is anchored to the cell wall via the highly conserved ancillary 
protein 2 (47, 84). Biochemical and structural analysis of the pilus led to speculation that 
disruption of the isopeptide bond would substantially compromise the integrity of the pilus. 
Indeed, the loss of one isopeptide bond causes a weakened ability to withstand stressors 
such as thermal stability or trypsin-resistance, and this pattern is even more prominent in 
mutants devoid of both isopeptide bonds (85). Other studies have since supported the 
stability-conferring properties of the isopeptide bonds and illustrated that its rigid and 
inextensible nature allows the pilus to withstand mechanical pressures such as coughing 
(85, 86). This works through the constant breaking of the isopeptide bonds due to 
mechanical pressure followed immediately by the automatic restoration of the bonds such 
that the majority of the energy subjected to the pilus is lost as heat, rather than through a 
more permanent loss of integrity (86–88). The pilus has also been shown to adhere to 
human tonsil epithelia, which is a major initial site for S. pyogenes upper respiratory tract 
infection (12, 89). Moreover, deletion of the major pilus subunit results in reduced adhesion 
to pharyngeal cell lines compared to the wildtype strain, with the greatest disparity 
occurring at earlier time points (<30 minutes), suggesting that the pilus is transiently 
regulated (90). Despite these findings, there is no evidence directly validating the major 
pilus subunit as the agent responsible for adhesion; instead, studies predict that ancillary 
protein 1 interacts with host ligands to mediate adhesion (91–93). 
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1.5.3.2. Collagen-binding protein 
Some strains harbour the pilus ancillary protein 1, otherwise referred to as the collagen-
binding protein, Cpa. Most commonly, studies have determined a pilus model in which 
Cpa is located at the tip of the pilus, thus naming it ancillary protein 1. Depending on the 
strain, however, S. pyogenes can encode cpa with the classical LPXTG motif that anchors 
Cpa to the cell wall, or an alternative (Q/E/V)(V/P)PTG motif that can be attached to the 
major pilus subunit, ancillary protein 2, or anchored to the cell wall through a locus-specific 
sortase encoded within the FCT region (47, 94–96). This structural inconsistency can be 
visualized using immunogold labelling, which has depicted Cpa at the top of the pilus (e.g. 
M1, M3, and M6), as well as at the base of the pilus (e.g. M49) (47, 97, 98). Despite the 
sequence variability between cpa of different strains, a common feature is the ability to 
bind collagen type I and type IV, leading to its hypothesized role in adherence during 
colonization, which is presently unconfirmed (76, 99). It has also been shown to contain a 
thioester bond, which may mediate an interaction with cognate receptors on host cells 
(100). In addition, deletion of cpa results in an attenuated ability for S. pyogenes to adhere 
to human lung and pharyngeal cell lines (89, 91). Clinical evidence from Cpa-seropositive 
patients indicated an association with people afflicted with arthritis and osteomyelitis, 
suggesting the possibility that Cpa interacts with collagen type I found in the bones and 
synovia (99). Thus, the combination of evidence suggests that Cpa can be utilized by S. 
pyogenes in a variety of ways in order to establish itself in the host, and that for some 
strains it may be vital in the formation of tissue-specific infections. 
 
1.5.3.3. Fibronectin-binding proteins 
The FCT region can also encode genes for one or two FBPs: prtF1/sfbI and/or 
prtF2/pfbp/fbaB. These proteins, although structurally distinct, are functionally related in 
that they facilitate adhesion to fibronectin and are involved with S. pyogenes internalization 
via the α5β1 integrin (101–103). Architecturally, these FBPs consist of one to five tandem 
repeat domains that are directly proportional to the strength of fibronectin binding, and in 
some cases, internalization efficiency (104–106). Moreover some strains of S.pyogenes 
share sequence homology between these FCT region-encoded FBPs and other FBPs, such 
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as fbaA or sof, which are located near the emm genomic cluster (2, 107). The regulation of 
these FBPs can be remarkably precise, as it has been demonstrated that for some strains 
the FBPs are upregulated in oxygen-rich conditions and downregulated when carbon 
dioxide availability increases (106, 108). This may suggest a transient role for FBPs during 
initial colonization of the skin and respiratory tract, and that they become less involved 
during late, deep tissue stages of infection at which point the expression of other virulence 
factors involved in maintaining the infection are prioritized (44). Explorations of the M3 
and M18 serotypes have demonstrated that PrtF2 is partially responsible for binding human 
pharyngeal cells and subsequently mediating bacterial internalization into these host cells. 
Cumulatively, these data substantiate the idea that the FCT region-encoded FBPs may be 
critical during initial adhesion to the host, as well as in progressing to an infectious state 
(109, 110). 
 
1.5.3.4. The relationship between the fibronectin-binding, 
collagen-binding, T-antigen region and tissue tropism 
The type of FCT region (i.e. FCT-1 through FCT-9) has been suggested to play a role in 
tissue tropism. For example, epidemiological data has shown that approximately 80% of 
skin isolates (emm pattern D) encode the FCT-4 region, whereas less than 15% of throat 
isolates (emm pattern A‒C) encode the FCT-4 region (25). Experimental analysis, 
however, does not appear to demonstrate major differences in vitro for adherence of 
different throat and skin isolates to a series of cell lines (111). Further complexity regarding 
S. pyogenes tissue tropism is introduced when considering that FCT region genes are 
subject to global regulators that affect their transcriptional expression during different 
pathogenic scenarios (107).  
 
1.6. Regulation in Streptococcus pyogenes 
Having evolved alongside humans throughout history, S. pyogenes has adapted incredibly 
well to our various tissues in order to cause infection and subsequently colonize our bodies. 
In particular, S. pyogenes has demonstrated an aptitude for immune avoidance, niche 
colonization, and in general, mitigating pathology in order to foster an ideal 
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microenvironment that is conducive to persistence within its host. A key factor in this 
remarkable feat is the regulation of virulence. In a multifaceted approach, regulation in S. 
pyogenes involves a circuit of coordinated gene regulators that respond to molecular cues 
from the host and environment. The S. pyogenes transcriptome is controlled by at least 13 
two-component systems and 30 known stand-alone regulators (>100 including putative 
gene regulators) (12). As such, for the purpose of this thesis, we will focus on some of the 
key regulators and how they influence survivability and pathogenesis.  
 
1.6.1. CovRS 
A prominent two-component system in S. pyogenes is the CovRS system, which primarily 
responds to environmental stress signals, such as antimicrobial peptides, increased 
temperature, iron starvation, or excess Mg2+ (112–114). Similar to other two-component 
systems, the process of regulation begins with a membrane-bound histidine kinase sensor, 
CovS, which then autophosphorylates and subsequently transfers the phosphoryl group to 
the response regulator, CovR (115, 116). This results in the dimerization of CovR, which 
is then able to bind DNA and modulate gene expression (117). The CovRS system is known 
to regulate the transcription of approximately 15% of the S. pyogenes genome, with an 
emphasis on virulence factors. Most commonly, CovRS acts to repress the expression of 
genes, including DNAses, cytolysins, and the hyaluronic acid capsule (118). Distinctively, 
the CovRS system appears to activate the transcription of the SpeB protease (119). It has 
also been documented that a non-functioning CovRS system leads to a hypervirulent 
phenotype, such as that which occurs in the globally-circulated M1T1 clone (120). Genetic 
analysis of the M1T1 clone unearthed a frameshift mutation in covS, inhibiting action of 
the CovRS system (121, 122). This hypervirulent phenotype is characterized by increased 
expression of virulence factors, such as the hyaluronic acid capsule and SpeA, and reduced 
expression of SpeB (12, 70, 123). The outcome of this mutation imparts CovRS mutants, 
such as the M1T1 strain, with a proclivity for systemic infection while being resistant to 
phagocytosis (121). 
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1.6.2. Mga 
Stand-alone regulators account for a considerable portion of S. pyogenes regulation, and 
one of the best-studied is Mga. The chief function of Mga is to control the expression of 
several genes, particularly the M protein, genes involved in metabolism, and immune 
evasion genes; however, it has also been shown to regulate the primary regulator of the 
FCT region, rofA/nra (124, 125). All strains of S. pyogenes encode for one of the two mga 
alleles, which are suspected to contribute to tissue tropism [mga-1 (throat isolates) and 
mga-2 (skin isolates/generalists)] (124, 126). Regardless of the mga variant, this regulator 
is consistently expressed during the exponential growth phase that most frequently occurs 
during early stages of infection (126, 127). Therefore, it is likely that Mga transcriptionally 
upregulates genes involved with the initial acute stage of infection and adhesion factors 
that prevent early mechanical clearance of S. pyogenes. 
 
1.6.3. RofA/Nra 
All strains of S. pyogenes encode RofA and/or Nra, and may additionally contain RALP3 
and/or RivR, which are all members of the RofA-like protein family (119, 128). Typically, 
these regulators are associated with the transition between the exponential phase and early 
stationary phase of growth (129). RofA and Nra, which notably share 63% sequence 
homology, are both encoded within the FCT region and attune the transcription of the genes 
encoded therein (129). Specifically, RofA directly upregulates transcription of the pilus, 
prtF1, as well as cpa and itself concurrently through an intergenic binding sequence (130). 
Peculiarly, Nra, which is found in a more limited range of S. pyogenes serotypes, is 
repeatedly described as a negative repressor of the aforementioned FCT region genes as 
well as prtF2. A possible explanation for this functional dichotomy may relate to the sites 
of infection for rofA+ and nra+ strains, which preferentially infect and colonize the throat 
and skin, respectively. Thus, these strains may differ in their requirements for spatial or 
temporal regulation in order to combat site-specific challenges (49, 126, 131). 
 
Although Nra is generally reported as a negative repressor of FCT region genes, its activity 
appears to be strain-specific as it has also been described as a positive regulator for cpa in 
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an M53 skin infection strain (132). Distinctively, some strains appear to have forfeited their 
use of Nra while maintaining their pathogenicity. For instance, MGAS315 (isolated from 
a patient with STSS) naturally produces negligible levels of pili, partially attributed to a 
non-synonymous mutation in nra that results in attenuated regulatory activities (133, 134). 
Furthermore, introduction of an overexpressed Nra plasmid demonstrates that genes within 
M3 isolates are categorically upregulated by Nra (133). Relatedly, M18 strains appear to 
harbour an early stop codon in nra, effectively truncating it during translation, and although 
this mutation has not been studied, it is tempting to speculate that expression of Nra in M18 
isolates would also upregulate numerous genes (135). This research suggests that for strains 
in which Nra acts as a positive regulator, basally high expression levels may be 
evolutionarily disadvantageous to S. pyogenes (133).  
 
Given that there are numerous RofA and Nra binding sites present throughout the genome, 
these regulators also appear to have a function with regards to global virulence (125, 129, 
131). This is further supported by studies that have demonstrated RofA and Nra activity 
leads to transcriptional downregulation of many genes related to virulence, including the 
hyaluronic acid capsule, SpeA, the SpeB protease, the cytolytic toxin streptolysin S, as well 
as Mga (125, 129, 131, 136). The act of downregulating Mga, which typically upregulates 
both RofA and Nra, further highlights the dynamic interplay between regulatory bodies in 
S. pyogenes and how they communicate to coordinate infection and sustain colonization. 
 
1.6.4. MsmR 
The FCT region can also encode the stand-alone regulator msmR, but its presence in this 
locus only occurs in strains that also encode prtF2 (77, 137). Principally, MsmR is involved 
in the upregulation of FBPs, regardless of their location within the genome (137). 
Interestingly, MsmR has been shown to simultaneously upregulate cpa and nra, which 
emphasizes the significance of expressing antithetical regulators to fine-tune virulence and 
colonization. Transcriptional regulation by MsmR also appears to function antipodally to 
Nra, regardless of the strain; that is, when Nra acts as a repressor, MsmR generally acts as 
an activator, and vice versa (119, 132). Collectively, the interconnected network of 
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regulators in S. pyogenes exemplifies the necessity to precisely modulate virulence factors 
during each strain’s unique life cycle.  
 
1.7. Rationale and hypothesis 
S. pyogenes resides within the throats of several hundred million people, yet many of the 
bacterial factors that help initiate and maintain pathogenicity remains unelucidated within 
the context of colonization and an acute pharyngeal infection. The FCT region is of 
particular interest since studies detailing its role during infection are less intensively 
studied compared to other surface-linked virulence factors, such as the M protein or 
hyaluronic acid capsule. Additionally, this study provides an exploratory opportunity to 
characterize the genes found within the FCT region of a strain that was isolated from an 
outbreak of ARF, MGAS8232 (135).  
 
During the early stages of pharyngeal infection by S. pyogenes, adherence factors aid in 
the onset of infection by adhering to host tissue to prevent the rapid and initial clearance 
of bacteria (44, 45). Three components often implicated in this mechanism are the pilus, 
its commonly associated collagen-binding protein, and FBPs, all of which are encoded 
within the FCT region of MGAS8232 (Figure 1). I hypothesized that these factors would 
be crucial for S. pyogenes to initiate infection in the nasopharynx of mice.  Using a genetic 
deletion of the FCT region (from the start of cpa until the end of prtF2), I predict that in 
vitro binding of S. pyogenes to relevant human tissue will be reduced. Moreover, using our 
transgenic murine nasopharyngeal infection model, for which MGAS8232 has previously 
been verified to consistently infect, I speculate that the deletion of the FCT region will 
inhibit the ability for S. pyogenes to establish itself in the nasal turbinates.  
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Figure 1. The FCT-3 region, and the adjacent upstream and downstream genes, 
found in S. pyogenes MGAS8232. 
The genetic organization of the FCT-3 region. The small arrows delineate the flanking 
boundaries of the portion of the FCT region that was chromosomally deleted in the ΔFCT 
mutant. 
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Chapter 2: Methods 
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2.1. Ethics Statement 
All animal experiments were completed under Animal Use Protocol (AUP) Number 2017-
024 in compliance with the Canadian Council on Animal Care Guide to the Care and Use 
of Experimental Animals, and was approved by the Animal Use Subcommittee at Western 
University (London, ON, Canada) (Appendix I). 
 
2.2. Bacteria 
A complete list of the bacterial strains used in this study can be found in Table 2. 
 
2.2.1. Escherichia coli 
E. coli were grown in Luria-Bertani (LB) broth (Thermo Fisher Scientific; Waltham, MA, 
USA) aerobically with shaking at 37°C. During molecular cloning, E. coli were grown on 
brain heart infusion (BHI) broth (BD Biosciences; Franklin Lakes, NJ, USA) with 1.5% 
(w/v) agar (Thermo Fisher Scientific) and 150µg mL-1 erythromycin (Sigma-Aldrich 
Canada; Oakville, ON, Canada) when required. Frozen stock cultures were stored at -80°C 
in  LB broth with 20% (v/v) glycerol. 
 
2.2.2. Streptococcus pyogenes 
S. pyogenes were grown in Todd Hewitt broth (BD Biosciences) supplemented with 1% 
(w/v) Bacto yeast extract (BD Biosciences) (THY) statically at 37°C. During molecular 
cloning, THY media was supplemented with 1.5% (w/v) agar and/or 1µg mL-1 
erythromycin. Frozen stocks were stored at -80°C in THY broth with 20% (v/v) glycerol. 
 
2.2.3. Streptococcus pyogenes growth curves 
S. pyogenes MGAS8232 (wildtype and ΔFCT) were grown from frozen -80°C stocks and 
subcultured at 1:100 for 2 days until day 3, on which 100mL bottles of pre-warmed THY 
media were inoculated with 6mL from the overnight culture and incubated at 37°C until 
early exponential phase. Optical densities (OD) were measured at regular intervals using a 
spectrophotometer (DU 530 Life Science UV/Vis Spectrophotometer, Beckman Coulter  
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Table 2. Bacterial strains used in this study 
Strain Description Source 
Escherichia coli   
XL1-Blue Molecular cloning strain Stratagene 
Streptococcus pyogenes  
MGAS8232 M18 serotype isolated from a patient 
during an acute rheumatic fever 
outbreak (GenBank accession: 
AE009949.1) 
(135) 
MGAS8232 ΔFCT FCT region deletion mutant in the strain 
MGAS8232 
This study 
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Canada LP; Mississauga, ON, Canada). Bacterial cultures were then adjusted to an OD600 
of 0.02 before being loaded into sterile 96-well plates. Bacteria were grown with periodic 
shaking and OD600 measurements were obtained every 10 minutes for 20 hours using the 
Synergy HTX Multi-Mode Microplate Reader (BioTek; Winooski, VT, USA). 
 
2.3. Molecular cloning 
This section details the methodologies that were used to generate the ΔFCT mutant. 
 
2.3.1. DNA visualization 
DNA samples were loaded into wells of a 1% (w/v) agarose gel in TAE (40 mM Tris-
acetate, 1 mM EDTA) buffer along with a 1-kb Plus DNA ladder (Invitrogen; Carlsbad, 
CA, USA). Gels were run at 100V for 1 hour using the PowerPac 200 Electrophoresis 
Power Supply and Chamber (Bio-Rad Laboratories; Hercules, CA, USA) and subsequently 
stained in 0.05% (v/v) ethidium bromide in TAE buffer for 20 minutes. DNA gels were 
then visualized using ultraviolet light on a gel doc (Bio-Rad Laboratories). 
 
2.3.2. Sequencing of DNA 
DNA samples (with the inclusion of primers when necessary) were sequenced by the 
Sequencing Facility at the John P. Robarts Research Institute in London, ON, Canada. 
Primers used for sequencing can be found in Table 3. 
 
2.3.3. Plasmid isolation from Escherichia coli 
Plasmid DNA was isolated from overnight cultures of E. coli using the instructions as 
outlined by the QIAprep Spin Miniprep Kit (Qiagen, Hilden, Germany). A complete list of 
plasmids can be found in Table 4. 
 
2.3.4. Genomic DNA isolation from Streptococcus pyogenes 
To isolate total genomic DNA from S. pyogenes, 2mL of an overnight culture was 
centrifuged at 15,000 × g for 2 minutes. Bacteria were washed with 1mL 0.2mM sodium  
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Table 3. Primers used in this study 
Primer Primer sequence (5’ → 3’)a 
Primers used to generate the ΔFCT construct 
FCT up KpnI for CGC GGTACC GAGGAATGCTAACTGCAAAT 
FCT up PstI rev CGC CTGCAG CCTCTTTTGCAATATATCCTC 
FCT down PstI for CGC CTGCAG TCATCATGTTAAGATAAGCTG 
FCT down BamHI rev CGC GGATCC TCTTCACTTCACTACTAGCAG 
Primers used for sequencing and deletion confirmation 
M13 for GTAAAACGACGGCCAGT 
M13 rev CAGGAAACAGCTATGAC 
FCT integration for CAGCAAGTTTCAATATGCTG 
FCT integration rev AACACAGACATAGTAACGAC 
Internal primers used during qRT-PCR 
gyrA RT for GGTTCGTATGGCTCAGTGGT 
gyrA RT rev TTCTCTTTCGCTTCCATCGT 
Int cpa for GCAGAACCATACTCTGTAACAG 
Int cpa rev CATTAAAGTCTGGATCAATCG 
Int tee18.1 for CAGGAGTGATTGATGGTTTAG 
Int tee18.1 rev AACATCAACTGTCCATTGTTG 
Int prtF2 for GGAATGGCTTACATTTATTCTG 
Int prtF2 rev CACCTGAAACAATATCTGGTG 
a
 Restriction endonuclease cut sites are underlined 
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Table 4. Plasmids used in this study 
Plasmid Description Source 
pG+host5 E. coli → Gram-positive shuttle vector; 
temperature-sensitive, erythromycin resistant 
(138) 
pG+host5::ΔFCT FCT region deletion construct chromosomally 
inserted into S. pyogenes MGAS8232 
This study 
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acetate then centrifuged again as described. Cells were then lysed with 500µL of a 50mM 
EDTA solution with 0.2% (v/v) sodium dodecyl sulphate (SDS) and 0.02µg RNase and 
were incubated for 1 hour at 70°C. Following, 50µL of 5M potassium acetate was then 
added for 1 hour at -20°C before being centrifuged as described for 10 minutes. The 
supernatant was then transferred to a tube with 1mL ice-cold 95% ethanol and left for 1 
hour at -20°C. The suspension was centrifuged as described for 10 minutes and the pellet 
was washed in 1mL ice-cold 70% ethanol. The solution was then centrifuged again, and 
the supernatant was discarded. The DNA pellet was then air-dried and resuspended in 
100µL sterile water from the MilliQ purification filtration system (EMD Millipore; 
Darmstadt, Germany) before being stored at -20°C. 
 
2.3.5. Polymerase chain reaction 
All primers used in this study were obtained from Sigma-Aldrich (Table 3). For a 100µL 
polymerase chain reaction (PCR), the mixture consisted of 5× high-fidelity buffer (Thermo 
Fisher Scientific), 0.7µL of the high-fidelity DNA polymerase Phusion (Thermo Fisher 
Scientific), 3mM deoxyribonucleotide triphosphate (dNTP) (Roche; Basel, Switzerland), 
2mM magnesium chloride (Thermo Fisher Scientific), 1µM of each primer (forward and 
reverse), and 2µL of DNA. All reactions were performed in an MJ Mini or MJ Research 
PTC-200 Thermal Cycler (Bio-Rad Laboratories) using the DNA amplification parameters 
as follows: 98°C for 5 minutes for initial denaturation of DNA; 98°C for 30 seconds, 30 
seconds at the appropriate melting temperature, 72°C for extension (time: 30 seconds per 
1 kb), repeated for 35 cycles; a final extension step at 72°C for 7 minutes before an 
indefinite 4°C step before sample removal. 
 
2.3.6. Restriction digests and ligations 
DNA restriction endonuclease digests were performed as per the manufacturer’s 
instructions (New England BioLabs; Ipswich, MA, USA) before purification using the 
QIAquick PCR Purification Kit (Qiagen). 
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Purified endonuclease-digested DNA was ligated into the appropriate vector (10 vector:1 
insert) using = T4 DNA Ligase (New England BioLabs) and incubated at 16°C for 1 hour.  
 
2.3.7. Generation of competent Escherichia coli cells 
To prepare competent rubidium chloride cells, an overnight culture of E. coli was 
subcultured into 100mL PSI broth [2% (w/v) Bacto tryptone (BD Biosciences), 0.5% (w/v) 
Bacto yeast extract, 0.5% (w/v) magnesium sulphate, pH = 7.6] at a 1:100 dilution and 
grown at 37°C with shaking to an OD600 of 0.5. The bacteria were placed on ice for 15 
minutes and then centrifuged at 5,000 × g for 5 minutes at 4°C. The pellet was resuspended 
in 40mL TfbI buffer [15% (v/v) glycerol, 100 mM rubidium chloride, 30 mM potassium 
acetate, 10 mM calcium chloride, 50 mM manganese chloride, pH = 5.8] and incubated on 
ice for 15 minutes. Bacteria were centrifuged as stated above and the resulting pellet was 
resuspended in 4mL TfbII buffer [15% (v/v) glycerol, 75 mM calcium chloride, 10 mM 3-
(N-morpholino) propanesulfonic acid, 10 mM rubidium chloride, pH = 6.5] and stored in 
200µL aliquots at -80°C. 
 
2.3.8. Transformation of competent Escherichia coli cells 
To start, 10µL of plasmid DNA from ligation reactions were added to thawed rubidium 
chloride competent E. coli cells and incubated for 30 minutes on ice. Bacteria were then 
placed in a 42°C water bath for 45 seconds followed by incubation on ice for 2 minutes. 
Afterwards, 900µL of LB broth was added to the cells and incubated for 1 hour at 37°C 
with shaking, and then 150µL of the bacteria were spread over BHI agar supplemented 
with 150µg mL-1 erythromycin and incubated overnight at 37°C. 
 
2.3.9. Generation of competent Streptococcus pyogenes cells 
To prepare competent S. pyogenes cells, an overnight culture was subcultured at a 1:50 
dilution into 100mL of THY broth containing 0.6% glycine for 2 hours at 37°C. Following, 
5mg of hyaluronidase (Sigma-Aldrich) was then added and the culture was grown to an 
OD600 of 0.3. Bacteria were centrifuged at 6,000 × g for 5 minutes and the pellet was 
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washed once with 40mL of 15% (v/v) glycerol. The cells were then resuspended in 4mL 
of 15% (v/v) glycerol and stored in 200µL aliquots at -80°C. 
 
2.3.10. Electroporation of competent Streptococcus pyogenes 
cells 
Plasmid DNA (~2µg) were mixed with thawed competent S. pyogenes cells and then 
transferred to a 2mm electroporation cuvette. The cells were pulsed exponentially at 2500V 
and 600Ω using a GenePulser (Bio-Rad Laboratories). Bacteria were then added to 10mL 
of THY and incubated for 3 hours at 37°C before centrifugation at 6,000 × g for 5 minutes. 
The cells were then resuspended in 1mL of THY broth and plated on THY agar 
(supplemented with 1µg mL-1 erythromycin if necessary) and incubated at 37°C overnight. 
 
2.3.11. Generation of Streptococcus pyogenes deletion mutant 
The temperature-sensitive, erythromycin-selection-marked plasmid pG+host5 was used to 
delete the FCT region from MGAS8232 via double homologous recombination events 
(135, 138) (Table 3).  
 
Two ~1,000bp segments directly upstream and downstream of the cpa and prtF2 genes, 
respectively, were amplified from wildtype MGAS8232 genomic DNA, digested using 
restriction endonucleases, and subsequently ligated into an accordingly-digested pG+host5 
vector (Figure 2A). The generated deletion construct was then transformed into competent 
E. coli XL1-Blue. 
 
The deletion construct isolated from E. coli XL1 Blue was then electroporated into S. 
pyogenes wildtype MGAS8232 and grown on THY agar supplemented with 1µg mL-1 
erythromycin at 30°C overnight; colonies were subsequently picked and grown in THY 
liquid media with erythromycin and incubated at 40°C for up to three days. The pG+host5 
plasmid is unable to replicate at this temperature, thus, erythromycin-resistance is 
indicative of chromosomal integration (Figure 2B). Clones that had the deletion construct 
successfully integrated (as verified by PCR) were subcultured 1:100 in THY liquid media 
28 
 
 
 
 
 
 
 
 
 
Figure 2: Deletion of the FCT-3 region from S. pyogenes MGAS8232. 
To genetically remove the FCT region, (A) adjacent segments upstream (US) and 
downstream (DS) were amplified by PCR, digested with restriction endonucleases, and 
ligated into the temperature-sensitive, erythromycin resistance (ermR)-marked pG+host5 
vector. (B) The knockout vector was then electroporated into S. pyogenes to remove the 
FCT region from the host chromosome during homologous recombination events that are 
contingent on the temperature-sensitive origin of replication (TS Ori) of the pG+host5 
vector.  
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without erythromycin at 30°C in order to resolve the plasmid (and the FCT region) from 
the chromosome. Bacterial cultures were patched onto THY agar with and without 1µg 
mL-1 erythromycin, wherein erythromycin-sensitive colonies had been cured of the 
pG+host5 plasmid (Figure 2B). These clones were then verified by DNA sequencing and 
PCR to confirm the successful deletion of the ΔFCT mutant. 
 
2.4. Protein visualization 
Protein samples were visualized using sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) and by Western blot. 
 
2.4.1. Sodium dodecyl sulphate polyacrylamide gel 
electrophoresis 
Proteins were mixed with Laemmli buffer [125 mM Tris pH 6.8, 50% glycerol, 4% SDS, 
5% β-mercaptoethanol, and 0.1% (w/v) bromophenol blue] and boiled for 5 minutes. 
Samples (20µL) were then run using SDS-PAGE on 12% (v/v) acrylamide gels in 
electrophoresis buffer [25 mM Tris, 250 mM glycine, 0.1% (w/v) SDS] for 30 minutes at 
85V then for 1 hour and 30 minutes at 150V. The gels were then stained with coomassie 
[0.1% (w/v) coomassie brilliant blue R-250 (Bio-Rad Laboratories), 45% (v/v) methanol, 
and 10% (v/v) acetic acid], and destained for visualization [10% (v/v) acetic acid, and 45% 
(v/v) methanol].  
 
2.4.2. Western blot 
To detect the superantigen SpeA in the wildtype and ΔFCT strains, samples run through 
SDS-PAGE were transferred onto polyvinylidene difluoride (PVDF) membranes 
(Amersham Hybond, GE Healthcare; Pittsburgh, PA, USA). This was accomplished by 
assembling the PVDF membrane and SDS-PAGE gel in a mini trans-blot cell (Bio-Rad 
Laboratories) and run for 1 hour at 100V in Western transfer buffer [48 mM Tris base, 39 
mM glycine, 0.037% (w/v) SDS, and 20% (v/v) methanol]. The PVDF membrane was then 
blocked using 5% (w/v) skim milk in tris buffered saline (TBS). Subsequently, the 
membrane was incubated at 4°C overnight with a polyclonal rabbit α-SpeA primary 
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antibody [(41), produced by ProSci; Poway, CA, USA] at a 1:1,000 dilution in TBS with 
1% (w/v) skim milk. The membrane was then washed in TBS with 0.1% (v/v) tween-20 
(Amresco, VWR International; Solon, OH, USA) (TBS-T) 3 times for 5 minutes per wash. 
The membrane was then incubated in darkness at room temperature for 1 hour with a goat 
α-rabbit IgG conjugated to IRDye800 secondary antibody (Rockland; Limerick, PA, USA) 
diluted 1:10,000 in TBS with 1% (w/v) skim milk. The membrane was subsequently 
washed 5 times with TBS-T, as described and then visualized using the LI-COR Odyssey 
Imaging System (LI-COR Biosciences; Lincoln, NE, USA). 
 
2.5. Cell Surface Extract 
To obtain cell wall fractions, wildtype and ΔFCT S. pyogenes were grown from frozen 
stocks into 10mL of THY and incubated overnight at 37°C before subculturing 1:100 into 
100mL bottles of pre-warmed THY and grown until an OD600 of 0.2‒0.4. The bacteria were 
then adjusted to an OD600 = 0.25 and centrifuged at 10,000 × g for 10 minutes. The pelleted 
cells were then washed once in PBS and centrifuged again. The cells were then resuspended 
in 1mL of cold protoplasting buffer [40% sucrose, 100mM KPO4 (pH = 6.2), 10mM 
MgCl2, Complete EDTA-free protease inhibitors (Roche), 2mg ml
-1 lysozyme (Sigma-
Aldrich), and 400U mutanolysin (Sigma-Aldrich)] and incubated at 37°C for 3 hours with 
constant but gentle movement. The bacteria were then centrifuged at 15,000 × g for 15 
minutes at 4°C and the supernatants (cell wall proteins) were collected and stored at -20°C. 
 
2.6. Trichloroacetic acid precipitation 
To obtain secreted proteins, wildtype and ΔFCT S. pyogenes were grown from frozen 
stocks into THY media and incubated overnight at 37°C before subculturing 1:100 into 
100mL bottles of pre-warmed THY and grown for 13 hours. The bacteria were centrifuged 
at 10,000 × g for 15 minutes at 4°C and the supernatant was subsequently drawn off and 
incubated with 50% trichloroacetic acid (TCA) (Sigma-Aldrich) for 30 minutes. The 
supernatant-TCA precipitations were then centrifuged as described above and the pellets 
were then washed with ice-cold acetone (Thermo Fisher Scientific) and centrifuged again 
as described and the supernatant was removed. The proteins were then resuspended in 1mL 
of 8M urea (BioShop Canada Inc; Burlington, ON, Canada) and stored at -20°C.  
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2.7. Extracellular matrix binding assay 
Wildtype S. pyogenes and the ΔFCT mutant were grown from frozen stocks into 10mL of 
THY media, followed by two days of subculturing. At this time, Corning Costar 9018 high-
binding 96-well plates (Corning; Kennebuck, ME, USA) were coated with 1µg of collagen 
type IV (Sigma-Aldrich) or fibronectin (Calbiochem, EMD Millipore Corporation; 
Temecula, CA, USA) dissolved in carbonate-bicarbonate buffer (0.2M sodium carbonate 
anhydrous, 0.2M sodium bicarbonate, pH = 9.6) overnight at 4°C. The day after, 6mL of 
the overnight S. pyogenes cultures were inoculated into separate 100mL bottles of pre-
warmed THY and grown until mid exponential phase after which their OD600 values were 
corrected to 0.25 before centrifuging the appropriate volume of bacteria at 15,000 × g and 
resuspending the pellet in phosphate buffered saline (PBS). While the bacteria were 
growing, the plates were washed three times using PBS with 0.05% (v/v) tween-20 and 
blocked for 2 hours with 5% (w/v) skim milk at room temperature before being washed 
three times as described. Afterwards, 100µL of bacteria (~1 × 107 CFUs) were added in 
triplicate to wells and incubated for 2.5 hours at 37°C. Plates were washed three times as 
described and fixed with 10% neutral buffered formalin (VWR International; Randor, PA, 
USA) for 40 minutes before washing three times again as described. Plates were then 
incubated with 50µL of 0.5% (w/v) crystal violet (Sigma-Aldrich) in 80% (v/v) sterile 
MilliQ water and 20% (v/v) methanol for 5 minutes at room temperature before being 
washed five times. Stain was solubilized in 5% (v/v) acetic acid with mild agitation for 10 
minutes. Colorimetric analysis was measured at OD590 using the Synergy HTX Multi-
Mode Microplate Reader (BioTek). 
 
2.8. Human cell culturing 
The pharyngeal cell line Detroit-562 (obtained from Dr. Joe Mymryk, Western  University) 
was grown in sterile 75cm2 tissue culture (TC)-treated flasks (Falcon, Corning; Corning, 
NY, USA) in 14mL of minimum essential medium (MEM) (Gibco, Life Technologies; 
Grand Island, NY, USA) supplemented with 10% (v/v) heat-inactivated fetal bovine serum 
(Sigma-Aldrich), 100 µg mL-1 streptomycin (Life Technologies), and 100 U mL-1 
penicillin (Life Technologies) at 37°C in 5% CO2 and washed 2 times every other day with 
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PBS (for ~6  days) to remove cellular debris. To split, flasks with cells at ~75% confluence 
were dissociated from the flask using 0.25% trypsin-EDTA (Gibco, Life Technologies). 
 
2.8.1. Pharyngeal cell line adhesion assay 
Detroit-562 cells were grown to confluence on 12 well TC-treated plates (Falcon, Corning) 
and then incubated for 2 hours in serum-free MEM. Three wells were dissociated using 
0.25% trypsin and counted using a haemocytometer (Hausser Scientific; Horsham, PA, 
USA) to obtain a representative average for the number of Detroit-562 cells per well, which 
was used to determine the number of bacterial CFUs to use during the assay [multiplicity 
of infection (MOI) = 100]. During this time, 6mL of an overnight culture S. pyogenes that 
was previously grown and subcultured for two consecutive days was inoculated into 
100mL bottles of pre-warmed THY and grown until mid-exponential phase. The 
appropriate volume of S. pyogenes was centrifuged at 15,000 × g and the pellet was 
resuspended in serum-, and antibiotic-free MEM and inoculated with the Detroit-562 
monolayer for 2.5 hours at 37°C in 5% CO2. Each well was washed 3 times using PBS to 
remove non-adherent bacterial cells and the remainder was mechanically lysed in PBS with 
0.01% (v/v) Triton X-100 (VWR International) to detach the cells from the plate. The 
suspension was then serially diluted (neat → 10-6) and plated on trypticase soy agar (TSA) 
supplemented with 5% sheep’s blood (BD Biosciences) for bacterial enumeration the next 
day.  
 
2.8.2. Pharyngeal cell line invasion assay 
The invasion assay, which is a modification of the classical gentamycin protection assay, 
follows the procedure as outlined in section 2.8.1 with an additional step. Briefly, after S. 
pyogenes were incubated with the confluent monolayer of Detroit-562 cells for 2.5 hours, 
the wells were washed twice with PBS and incubated in MEM supplemented with 100µg 
mL-1 gentamycin (Sigma-Aldrich) for an additional 1.5 hours at 37°C in 5% CO2 to kill 
extracellular bacteria. As described above, the cells were then detached from the plates in 
PBS with 0.01% (v/v) Triton X-100, serially diluted, and plated for bacterial enumeration 
the next day. 
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2.9. Mice 
Transgenic C57BL/6 mice expressing the MHC class II molecules HLA-DR4/DQ8 or 
HLA-DQ8 alone were donated from the Kotb laboratory and were since housed and bred 
in the West Valley Barrier Facility at Western University (41, 139). S. pyogenes inoculum 
preparation and mouse infection were performed as previously described (140).  
 
2.9.1. Murine nasopharyngeal infection  
A timeline of the infection model can be found in Figure 3A; to begin, mice were given 
water supplemented with 2mg mL-1 neomycin sulphate (VWR International) prior to and 
throughout the course of infection in order to inhibit their endogenous nasal microbiota. 
 
Wildtype S. pyogenes and the ΔFCT mutant were grown from freezer stocks in THY and 
subcultured 1:100 for two days. On the third day, 6mL of the overnight cultures were then 
inoculated into separate pre-warmed bottles of THY and grown to an OD600 of 0.2‒0.4 and 
the appropriate volume was resuspended in Hank’s Balanced Saline Solution (HBSS) (Life 
Technologies). Mice were anesthetized with isoflurane (USP, Baxter International; 
Deerfield, IL, USA) and intranasally inoculated with ~5 × 107 bacterial CFUs per nostril. 
Twenty-four or 48 hours post-inoculation, mice were sacrificed and their complete nasal 
turbinates (cNTs) were harvested (Figure 3A, Figure 3B). Subsequently, the cNTs were 
homogenized in HBSS and a portion of the homogenate was serially diluted (neat → 10-7) 
and then plated on TSA supplemented with 5% sheep’s blood for bacterial enumeration 
the following day. The remainder of the homogenate was stabilized in RNAprotect Cell 
Reagent (Qiagen) for 5 minutes at room temperate, centrifuged at 15,000 × g for 10 minutes 
to discard the supernatant, and stored at -80°C until future use. 
 
2.9.2. RNA isolation 
S. pyogenes were grown in vitro to an OD600 of 0.2 (early exponential phase) or 0.8 (late 
exponential phase) before being incubated with 1mL of RNAprotect Cell Reagent for 5 
minutes at room temperature, centrifuged at 15,000 × g for 10 minutes to discard the 
supernatant, and stored at -80°C until future use.  
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Figure 3. Mouse infection timeline 
(A) Two days prior to infection, mice were given 2mg mL-1 neomycin water. They were 
then inoculated nasally with the wildtype or ∆FCT strain of S. pyogenes MGAS8232 and 
sacrificed 24 or 48 hours later. (B) Their complete nasal turbinates (pink) were then 
harvested and processed RNA extraction and/or bacterial enumeration. 
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RNA-protected bacterial pellets or murine cNT homogenates were resuspended in 500µL 
of Tris-EDTA + glucose (2mM EDTA, 10mM Tris, 25% glucose) buffer with 100µg of 
lysozyme and 50 U of mutanolysin followed by incubation for 1 hour at 37°C. The cells 
were then centrifuged at 20,000 × g and the pellet was resuspended in 500µL of 
streptococcal lysis buffer (50mM EDTA, 0.2% SDS) with 100µg of proteinase K and 
incubated for 2 hours at 65°C. RNA was then extracted and purified using the RNeasy Kit 
(Qiagen) as per the manufacturer’s instructions. 
 
2.10. Quantitative real-time polymerase chain reaction  
Gene-specific primers were designed for cpa, tee18.1, and prtF2 with amplicon lengths of 
~200bp and amplified from wildtype MGAS8232 genomic DNA to generate standards for 
each gene (Table 3). RNA isolated from murine tissue or in vitro S. pyogenes cultures were 
used to generate cDNA using random primers (Invitrogen) and SuperScript II Reverse 
Transcriptase (RT) (Invitrogen). The genomic DNA and cDNA were then quantified using 
a NanoDrop One/OneC Microvolume UV-Vis Spectrophotometer (Thermo Fisher 
Scientific). The concentration was adjusted to 5ng µL-1 and eight 10-fold serial dilutions 
were prepared in purified MilliQ water. The quantitative reverse transcriptase (qRT)-PCR 
reactions were performed with SensiFAST SYBR Green No-ROX Kit (Bioline, Meridian 
Bioscience Inc; London, ON, Canada) as per the manufacturer’s instructions using the 
previously-designed gene-specific primers. All reactions were performed with their 
respective standards, a no-template control, and a control excluding RT. Samples were run 
on the Rotor-Gene 6000 (Corbett Life Sciences; Sydney, NSW, Australia) with the 
following amplification conditions: 95°C for 5 minutes, denaturation for 10 seconds at 
95°C, 10 seconds at 60°C to anneal primers, and a 20 second extension at 72°C (45 cycles). 
 
2.11. Statistical Analyses 
Data were analyzed using the unpaired t-test or the one-way analysis of variance (ANOVA) 
with Tukey’s post-hoc test, as stated in the figure legends. A p value less than 0.05 as 
determined by Prism software (GraphPad Software; La Jolla, CA, USA) was classified as 
statistically significant.  
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3.1. Confirmation of the S. pyogenes ΔFCT deletion mutant 
Using the methods described in section 2.3.11, a clean deletion of the FCT region was 
produced in the S. pyogenes strain MGAS8232 and confirmed by DNA sequencing. The 
deletion was also verified by PCR using integration primers that flanked the excised region 
(Figure 4A). A series of in vitro assays were then performed to validate this mutant and 
ensure no pleiotropic effects occurred due to a theoretical secondary mutation that could 
have occurred during the mutagenesis procedure. Using a cell surface extract and a TCA 
precipitation to visualize the expression of cell surface-linked and secreted proteins, 
respectively, we were able to verify that the ΔFCT mutant retains a similar protein 
expression profile to the wildtype strain (Figure 4B, Figure 4C). As discussed earlier, the 
superantigen SpeA is necessary to instigate an acute infection in our murine 
nasopharyngeal model, and thus it was necessary to confirm that production of this toxin 
was unchanged by the molecular cloning process. The TCA precipitations that were 
previously performed were used as samples to generate an α-SpeA Western Blot. From this 
process, we determined that there was no obvious difference in SpeA production in the 
ΔFCT mutant (Figure 4D). Additionally, the wildtype strain and ΔFCT mutant were grown 
for 20 hours to generate comparative growth curves. Since the two strains did not exhibit 
differential growth, we were able to ensure that removal of the FCT region did not lead to 
any discernable growth defects in THY broth (Figure 4E). 
 
3.2. S. pyogenes FCT region genes mediate adhesion to collagen 
type IV and fibronectin 
Since several genes encoded within the FCT region have been implicated in adhesion, we 
first sought to evaluate the adhesion capabilities of the ΔFCT mutant compared to the 
wildtype strain. It has been well-documented that collagen type IV and fibronectin are 
significant constituents of the nasopharyngeal ECM, and that the ability for bacteria to 
adhere to them may contribute to streptococcal infection (99, 141–144). In particular, 
collagen type IV is the most abundant ECM protein that underlays epithelial cells, and 
although fibronectin is a minor component of the basement membrane, it is constantly 
being secreted in order to mediate adhesion and migration of host cells (145, 146). In order  
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Figure 4. Confirmation of the ∆FCT mutant and subsequent in vitro analyses.  
(A) Integration primers flanking the FCT region were amplified using PCR followed by 
DNA gel electrophoresis to confirm that the FCT region was deleted from the genome. In 
vitro analyses were used to assess (B) surface protein expression by cell surface extract, 
(C) secreted protein expression by trichloroacetic acid preparation, and (D) SpeA 
superantigen expression by Western Blot (purified SpeA and SpeC were used as positive 
and negative controls, respectively). (E) An automated BioScreen protocol was used to 
generate growth curves for the wildtype MGAS8232 and ∆FCT mutant strains to ensure 
that the ΔFCT mutant did not present any in vitro growth defects.  
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to examine the adhesion properties of the wildtype and ΔFCT strains, a bacterial adhesion 
assay was performed in which the bacteria were incubated with collagen type IV or 
fibronectin before being stained by crystal violet. We discovered that wildtype MGAS8232 
was entirely reliant on the presence of the FCT region in order to bind collagen type IV, 
whereas binding to fibronectin was only partially reduced in the ΔFCT mutant (Figure 5A, 
Figure 5B). These results demonstrate that under normal in vitro growth conditions, S. 
pyogenes can produce functional FCT region-encoded proteins, most likely Cpa and PrtF2, 
suggesting that they may be fundamental to the bacteria’s natural life cycle. 
 
3.3 The FCT region genes do not mediate adhesion to human 
pharyngeal cells by S. pyogenes 
A vital step in the life cycle of S. pyogenes is its prompt adherence to a susceptible human 
host; S. pyogenes can accomplish this task by utilizing numerous adhesion molecules. To 
examine the adherence capabilities of S. pyogenes to relevant human tissue, the pharyngeal 
cell line Detroit-562 was chosen due to its similarity of surface molecules with non-
transformed pharyngeal cells, as well as its ability to induce certain superantigens and 
DNAses that S. pyogenes cultured on its own is unable to express (147–149). In short, 
wildtype MGAS8232 and the ΔFCT mutant were incubated over a confluent monolayer of 
Detroit-562 cells, and after the non-adherent bacterial cells were washed away, the 
remainder were plated for bacterial enumeration. We detected no differences in the binding 
capabilities to Detroit-562 cells between the wildtype and ΔFCT strains (Figure 6). These 
results indicate that the genes encoded within the FCT region are not essential for 
adherence to these pharyngeal cells. It should be noted, however, that the natural 
environment of S. pyogenes consists of more than one cell type, and adherence to the host 
is a multifactorial event that needs to be explored further. 
 
3.4 S. pyogenes invasion of human pharyngeal cells is 
dependent on FCT region genes 
In addition to adherence, FCT region genes are heavily implicated in the ability of S. 
pyogenes to invade into host cells (101, 150, 151). Compared to other FBPs, PrtF2 (which  
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Figure 5: The FCT region facilitates adhesion to collagen type IV and fibronectin.  
Wells were coated with 1µg of human (A) collagen type IV, or (B) fibronectin, before 
incubation with ~ 1 × 107 S. pyogenes CFUs at 37°C. Non-adherent cells were washed off 
and the remaining cells were stained with 0.5% crystal violet before colorimetric analysis. 
Bars represent the mean ± SEM; unpaired t-test was used to determine statistical 
significance (***p<0.001, ****p<0.0001). 
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Figure 6. The FCT region does not influence adhesion to Detroit-562 cells. 
A confluent monolayer of the human pharyngeal cell line Detroit-562 was grown before 
incubation with S. pyogenes (MOI of 100) at 37°C in 5% CO2 for 2.5 hours. The non-
adherent bacterial cells were then washed away before disrupting the monolayer and 
plating the suspension for bacterial enumeration. Each data point represents one in vitro 
biological replicate. Error bars represent the mean ± SEM; statistical differences were 
evaluated using the unpaired t-test, (p>0.05). 
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is encoded by MGAS8232) is more commonly associated with severe S. pyogenes infection 
and is more likely to correlate with invasive disease (101, 143, 152, 153). As such, we 
wanted to characterize the natural invasive proficiency of our wildtype strain and elucidate 
whether the ΔFCT mutant retained the same invasion potential. To test this query, we 
utilized Detroit-562 cells in a similar fashion to our adhesion assay, but performed a 
gentamycin protection assay to eliminate extracellular S. pyogenes prior to enumeration. 
Strikingly, we discovered that removal of the FCT region completely eliminated the ability 
to invade these pharyngeal cells (Figure 7). This assay provides compelling evidence to 
reinforce the idea that the FCT region plays a significant role during host-cell invasion.  
 
3.5 S. pyogenes expresses cpa, but neither tee18.1 nor prtF2 in 
vivo 
Within the biological context of nasopharyngeal infection, S. pyogenes must be able to 
adhere to the nasopharynx and persist at the site of infection while withstanding an 
inundation of mucociliary defenses. Success during this stage can be ascribed in part to the 
repertoire of virulence factors and adhesion molecules. Therefore, we wanted to establish 
the in vitro and in vivo expression profiles of the adherence-implicated genes encoded 
within the FCT region of MGAS8232; this included: the major pilus subunit, tee18.1, the 
collagen-binding protein, cpa, and the FBP, prtF2 (Figure 1).  
 
In order to determine the expression of these genes in vitro, RNA was isolated from cultures 
of S. pyogenes that were grown to early and late exponential phase. We then used qRT-
PCR to measure the transcripts of these genes and normalized their concentration to the 
internal housekeeping gene, gyrA. We observed that cpa, tee18.1, and prtF2 were all being 
transcribed at both early and late exponential phase, with cpa being transcribed at levels 
higher than tee18.1 and prtF2 (Figure 8). Although not statistically significant, our data 
depicts a slight trend for higher transcription levels for all FCT region genes during late 
exponential phase, suggesting the possibility of temporal regulation for these genes. With 
regards to in vivo expression, mice were infected for 48 hours with wildtype MGAS8232 
and RNA was subsequently isolated from the cNTs before qRT-PCR analysis.  
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Figure 7. The FCT region is necessary for invasion into Detroit-562 cells. 
A confluent monolayer of the human pharyngeal cell line Detroit-562 was grown before 
incubation with S. pyogenes (MOI of 100) at 37°C in 5% CO2 for 2.5 hours followed by 1 
hour in media supplemented with 100µg mL-1 of gentamycin. The non-
adherent/internalized bacterial cells were then washed away before disrupting the 
monolayer and plating the suspension for bacterial enumeration. Each point represents an 
in vitro biological replicate. Error bars represent the mean ± SEM; statistical differences 
were evaluated using the unpaired t-test, (****p<0.0001). 
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Figure 8. S. pyogenes transcribes FCT region genes in vitro.  
mRNA was isolated from wildtype S. pyogenes MGAS8232 that was grown to early (OD600 
~0.2) and late (OD600 ~0.8) exponential phase. Transcription levels were quantified using 
qRT-PCR and normalized to the internal housekeeping gene gyrA (represented by the 
dotted line at y = 1). Bars represent the mean ± SEM (n = 4 per growth phase analyzed 
using duplicate values). 
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In addition to measuring the absolute concentration of these gene transcripts, we also used 
the 2-ΔΔCt method to compare the expression of these genes in wildtype-infected mice to 
their in vitro expression (154). Moreover, we infected mice with the ΔFCT mutant and ran 
qRT-PCR using RNA that was isolated from the extracted cNTS, which resulted in the 
readouts for all genes below the limit of detection (Appendix II). Using mice that were 
infected for 48 hours with wildtype MGAS8232, we observed that cpa transcripts were 
produced at levels significantly higher than tee18.1 and prtF2 transcripts (Figure 9A). 
Surprisingly, cpa transcripts in vivo were expressed in quantities comparable to in vitro 
samples, whereas tee18.1 and prtF2 transcription was considerably downregulated in vivo 
(Figure 9B). In fact, tee18.1 and prtF2 transcripts were identified at levels similar to what 
was found in mice infected with the ΔFCT mutant, that is to say, transcription was 
essentially undetectable (Figure 9A, Appendix II). These results suggest two possibilities: 
(1) the pilus and/or PrtF2 are not expressed throughout the course of acute pharyngeal 
infection, or (2) these proteins are regulated in a manner such that they are not detected 48 
hours post-inoculation. To investigate the second possibility that either tee18.1 and/or 
prtF2 would be transcribed during an earlier timepoint of infection, mice were again 
inoculated with wildtype MGAS8232, but cNTs were harvested for RNA extraction after 
24 hours. Similar to the 48 hour infection, cpa transcripts were detected at concentrations 
several thousand fold higher than tee18.1 and prtF2 transcripts (Figure 10A). Remarkably, 
transcription of cpa was greatly upregulated during a 24 hour infection compared to in vitro 
samples, and was approximately 36 times greater at this shorter timepoint compared to 48 
hours into infection (Figure 10A, Figure 10B, Appendix III). From this finding, we can 
insinuate that cpa is expressed during the earlier stages of nasopharyngeal infection, 
presumably to mediate adhesion to host tissue, and is subsequently downregulated as 
infection progresses. With regards to tee18.1 and prtF2, transcription was again 
exceedingly low and markedly downregulated compared to in vitro expression, indicating 
that the major pilus subunit and FBP were not expressed at this timepoint either (Figure 
10A, Figure 10B). These data suggest that the expression of certain FCT region 
constituents are regulated in a manner that differs during in vitro expression compared to 
an in vivo acute nasopharyngeal infection. 
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Figure 9. Expression of FCT region genes during a 48 hour murine nasopharyngeal 
infection. 
Transgenic mice expressing HLA-DR4/DQ8 were inoculated with 1×108 CFUs of wildtype 
S. pyogenes MGAS8232 and sacrificed 48 hours later. Their cNTs were then harvested and 
processed for RNA extraction. qRT-PCR was used to measure the mRNA transcription 
levels of cpa, tee18.1, and prtF2 and were then normalized to the housekeeping gene gyrA. 
Data are presented as (A) the concentration of mRNA transcripts (gyrA denoted by the 
dotted line at y = 1); and (B) the average fold change difference of gene transcription in 
wildtype-infected mice (n = 5) relative to in vitro cultures [n = 4 for both early (OD600 
~0.2) and late (OD600 ~0.8) exponential growth phases]. Bars represent the mean ± SEM; 
1-way ANOVA with Tukey’s post-hoc test was used to determine statistical significance 
(***p<0.001). 
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Figure 10. Expression of FCT region genes during a 24 hour murine nasopharyngeal 
infection. 
Transgenic mice expressing HLA-DR4/DQ8 were inoculated with 1×108 CFUs of wildtype 
S. pyogenes MGAS8232 and sacrificed 24 hours later. Their cNTs were then harvested and 
processed for RNA extraction. qRT-PCR was used to measure the mRNA transcription 
levels of cpa, tee18.1, and prtF2 and were then normalized to the housekeeping gene gyrA. 
Data are presented as (A) the concentration of mRNA transcripts (gyrA denoted by the 
dotted line at y = 1); and (B) the average fold change difference of gene transcription in 
wildtype-infected mice (n = 4) relative to in vitro cultures [n = 4 for both early (OD600 
~0.2) and late (OD600 ~0.8) exponential growth phases]. Bars represent the mean ± SEM; 
1-way ANOVA with Tukey’s post-hoc test was used to determine statistical significance 
(***p<0.001). 
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3.6 FCT region genes are not required for infection by S. 
pyogenes in the murine nasopharynx 
Ultimately, we sought to ascertain whether deletion of the FCT region would have any 
bearing on the ability of S. pyogenes to stimulate an acute nasopharyngeal infection in 
mice. Using the previously described murine infection model, cNTs were harvested 48 
hours post-inoculation and processed for bacterial enumeration. We discovered that 
transgenic mice expressing the HLA-MHC II molecule (alleles DQ8 and DR4/DQ8) were 
infected by the wildtype strain and ΔFCT mutant at comparable magnitudes (Figure 11). 
Taken together, these experiments provide convincing evidence that the FCT region does 
not play an essential role during acute nasopharyngeal infection by S. pyogenes 
MGAS8232. 
 
 
 
  
58 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Acute nasopharyngeal infection of transgenic mice by S. pyogenes. 
Transgenic mice expressing (A) HLA-DQ8, or (B) HLA-DR4/DQ8 were infected with 
~1×108 wildtype S. pyogenes MGAS8232 or the ΔFCT mutant for 48 hours before 
sacrifice. Their cNTs were then harvested and processed for bacterial enumeration. Each 
data point represents an individual mouse and statistical differences were evaluated by the 
unpaired t-test (p>0.05). 
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4. Discussion 
The evolution of S. pyogenes has resulted in a bacterium that is exquisitely adapted to its 
human host. Its capacity to establish infection, colonize, and persist in the human 
population can be attributed to its abundance of virulence factors. These molecular 
elements, and the precise regulation of them, permit S. pyogenes to successfully overcome 
environmental and metabolic challenges, adhere to host tissue, survive intracellularly, and 
circumvent the host immune system. The FCT region is a genetically diverse genomic 
locus that encodes such elements, many of which have been implicated in the life cycle of 
S. pyogenes by directly mediating adhesion, invasion, and regulation of locus-specific and 
chromosomally-distant virulence factors. 
 
In this study, I intended to examine the FCT region of S. pyogenes MGAS8232 in order to 
characterize its properties and functions and how it pertains to pharyngeal infection. I 
accomplished this aim by generating a mutant with the entire FCT region deleted, rather 
than single mutants of the investigated genes. However, this presented a challenge to 
determine which gene(s) were responsible for which results. Therefore, it became 
necessary to formulate interpretations of our results by carefully analyzing the data with 
respect to the available literature on how these genes act individually, as well as how they 
are predicted to behave collectively.  
 
Our first objective was to confirm that S. pyogenes possessed the capacity to bind ECM 
proteins that are found in the nasopharynx (146, 155). Remarkably, we discovered that the 
ΔFCT mutant had completely lost its ability to bind collagen type IV and had significantly 
reduced adherence to fibronectin (Figure 5A, Figure 5B). The most likely protein 
candidates responsible for this loss of phenotype are Cpa and PrtF2 as they are the only 
FCT region constituents known to directly bind ECM proteins (45, 156). With regards to 
collagen type IV, both Cpa and PrtF2 contain collagen-binding domains; these domains in 
PrtF2, however, are secluded from the extracellular milieu and are predicted to have a role 
in conferring structural stability against extremely high temperatures and low pH (109, 
157). For this reason, we infer that Cpa is likely mediating adhesion to collagen type IV. 
Intriguingly, many strains associated with pharyngitis and ARF exhibit weak binding to 
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collagen type IV, further supporting the notion that a significant portion of strain-
specificity originates from within the FCT region. (49, 99). PrtF2 has been described as an 
important adhesin during infection and colonization by S. pyogenes (106, 142). We 
substantiated this claim by demonstrating a reduction in fibronectin-binding capacity by 
MGAS8232 upon removal of the FCT region (Figure 5B). Although fibronectin-binding 
decreased substantially, there still remained some residual binding capabilities. This 
finding was logical, however, as analysis of the MGAS8232 genome illuminated the 
presence of a putative FBP, spyM18_0997 (an FbpA-like protein), encoded outside of the 
FCT region (135). Impressively, for strains that encode prtF2, it is typically considered a 
major factor in determining the tropism and severity of infection for that specific strain, 
and so, it is possible that in the absence of PrtF2, this putative FBP may be upregulated in 
an attempt to rescue fibronectin-binding (101, 104, 145, 152, 158, 159). From a regulatory 
perspective, it would be worthwhile to examine how S. pyogenes adapts to the loss of its 
major FBP(s) both in vitro and throughout an in vivo infection model. Additional future 
endeavours can explore the binding capabilities to different collagen types, as well as other 
ECM proteins, such as laminin, which is a major constituent of the basement membrane 
(160).  
 
It has previously been demonstrated in a number of serotypes that the FCT region is crucial 
for binding eukaryotic cells that are associated with different sites of infection (89, 90, 
161). We therefore sought to demonstrate this capacity in our strain against the human 
pharyngeal cell line Detroit-562 and observed that the absence of the FCT region did not 
impede the ability of S. pyogenes to adhere to these cells (Figure 6). This result conflicts 
with previous reports that implicate the FCT region genes in adherence to relevant human 
tissue (57, 89). It stands to reason that MGAS8232 may not be adept at directly binding 
human cells without the scaffold of ECM proteins. If this is the case, adhesion in the 
nasopharynx may transpire through an uncharacterized avenue. That is, it may be necessary 
for S. pyogenes to utilize a mechanism that disrupts the host epithelial barrier to expose the 
underlying ECM to permit adhesion. This is likely a dynamic process that features several 
virulence factors such as the hyaluronic acid capsule, which is able to alter cytoskeletal 
arrangements resulting in an opening of intercellular junctions; the protease SpeB, which 
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can directly degrade components of intercellular junctions; and/or streptolysin S, which 
may activate the host protein calpain inducing disruption of cell-to-cell linkages thereby 
allowing S. pyogenes to travel across the epithelial barrier and gain access to ECM proteins 
(67, 162–164). Conversely, MGAS8232 may indeed mediate adhesion to Detroit-562 cells 
via its FCT region genes, but the presence of other adhesion molecules, such as the 
hyaluronic acid capsule, may have rescued the adherence phenotype that we theoretically 
expected to decrease in the ΔFCT mutant, thereby confounding our results.  
 
Although our adhesion assay did not demonstrate any loss of binding capabilities to 
Detroit-562 cells, we speculated whether deletion of the FCT region would impact invasion 
of S. pyogenes. We identified an extraordinary phenotype in which invasion by the ΔFCT 
mutant is completely suppressed (Figure 7). This validates previous studies that have 
implicated the FCT region, and PrtF2 specifically, in invasion (101, 104, 143, 165, 166). 
Binding interactions between fibronectin and PrtF2 (and homologous FBPs) have been 
well characterized, and involve the FBP forming an energetically favourable β-zipper with 
fibronectin (105, 167, 168). Subsequently, S. pyogenes FBP can interact with a fragment 
of fibronectin that is hypothesized to stimulate α5β1 integrin clustering to promote invasion 
into the host cell (77, 109, 168). Moreover, epithelial cells, such as Detroit-562 cells, have 
been shown to secrete fibronectin to its apical surface, and together with saliva-derived 
fibronectin, S. pyogenes has ample opportunities to interact with fibronectin and initiate 
invasion (169–172). Importantly, PrtF2-mediated invasion is likely a major contributor to 
the intracellular life cycle; in an epidemiological study of S. pyogenes isolated from 
children, 80% of asymptomatic throat carriers were found to be prtF2+ (173). This 
hypothesis is substantiated by data that identified concurrent presence of prtF1 and prtF2 
were associated with high erythromycin resistance, suggesting that S. pyogenes may 
internalize into host cells using these FBPs as a means to evade immune detection and 
antibiotic treatment (159). Coupled with the lack of altered adhesion efficiency from 
Figure 6, our results demonstrate how FCT region-mediated adhesion and invasion are not 
necessarily linked in S. pyogenes as commonly described (101, 145, 174).  
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In this study, we discovered that during an in vivo murine nasopharyngeal infection, cpa 
was unequivocally being expressed both 24, and 48 hours post-inoculation, and that 
transcription of cpa was greater at the 24-hour timepoint (Figure 9A, Figure 10A). 
Accordingly, we can infer that Cpa is critical to the initial attachment of S. pyogenes to a 
susceptible host. Transcripts for tee18.1, however, were essentially undetectable (Figure 
9A, Figure 10A). This result was curious given that Cpa is often, albeit not always, 
predicted to be the pilus tip adhesin and is typically situated atop the pilus structure (47, 
97, 98, 100). Interestingly enough, in MGAS8232 cpa contains a VVPTG motif, which is 
one of the sequences recognized by srtC2, a specialized sortase encoded within the FCT 
region (95, 135). srtC2 is unique in that its catalytic domain is architecturally flexible 
thereby allowing it to interact with more variable substrates (96). This feature was likely a 
consequence of evolution to physically accommodate the strain- and serotype-specific 
sequences of the major pilus subunit and its ancillary protein(s). Thus, the possibility exists 
that Cpa is linked directly to the cell wall via an FCT region dedicated sortase. This would 
suggest that for some strains, it would not benefit S. pyogenes to consume energy to 
produce pili if the associated adhesin is able to be presented in a more efficient manner. 
 
Nevertheless, the lack of tee18.1 transcript needs to be further investigated since pilus 
assembly and presentation on S. pyogenes M18 serotypes is not well understood (49, 133, 
175, 176). This finding entails the possibility that some strains of S. pyogenes, such as the 
one used in this study, do not naturally express the pilus during its infectious life cycle, yet 
still transcribe the tee gene in vitro (Figure 8, Figure 9B, Figure 10B). A previous analysis 
of M3 serotypes, which share the FCT-3 variant that MGAS8232 has, determined that the 
pilus assembly mechanism was effectively nonexistent, and that presentation of the pilus 
on the bacterial cell was only accomplished by artificially upregulating the genes (133). 
We can therefore posit that the nature of the pilus may have resulted in some strains, such 
as MGAS8232, ablating expression of the pilus in vivo. This phenomenon could have been 
caused by the presence of other virulence factors that are sufficient at mediating adhesion, 
or perhaps as an approach to avoid immune detection. Hence, this finding further illustrates 
that selective regulation and production of the pilus is a critical factor that is dependant on 
strain-specific needs in vivo during the infectious life cycle. For instance, clinical M3 
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isolates are regulated in a manner that yields low or negligible levels of pili, which may 
reduce the adherence of the bacteria from host tissue and allow survival, replication, and 
dissemination in human blood (133). Disruption of the pilus assembly mechanism in an 
M1 strain drives the bacteria toward a virulent phenotype, implying that the pilus is active 
in maintaining colonization rather than promoting disease (98). This concept is further 
supported by a study that demonstrated how a marked increase in pilus production by an 
invasive M3 strain resulted in decreased virulence and increased adherence to human 
epithelial cells (177). The constitutive expression of pili, however, may be detrimental to 
S. pyogenes colonization. M1 serotypes require their pili to establish epithelial infection 
and colonization, yet due to the immunogenicity of the major pilus subunit, superfluous 
expression of their pili leads to recognition by phagocytes prompting a neutrophil-driven 
immune response that elevates S. pyogenes killing through neutrophil extracellular 
entrapment (178). Concerning MGAS8232, immunogold labeling or Western blot using 
antibodies raised against the major pilus subunit would provide definitive evidence 
regarding the expression of the pilus both in vitro and in vivo. 
 
With regards to the expression of prtF2, we discovered that no transcripts were being 
synthesized in vivo. Dissimilar to the situation concerning tee18.1, we are confident that 
MGAS8232 is able to transcribe and translate a functional PrtF2 protein, given that prtF2 
transcripts were produced in measurable quantities in vitro, and that our fibronectin-
binding assay clearly demonstrated that excision of the FCT region attenuates binding to 
fibronectin (Figure 5B, Figure 8). A plausible explanation for not detecting expression of 
prtF2 in vivo revolves around its regulation. Although PrtF2 is heavily implicated in direct 
adhesion to fibronectin, characterization of this protein has predominantly described its 
primary function as facilitating invasion into mucosal and skin-associated epithelial cells 
(101, 102, 152, 159, 174). Therefore, S. pyogenes must produce maximal concentrations 
of this protein when invasion is optimal, which occurs after the bacteria have adhered 
successfully to their site of infection. Transcription analysis of prtF2 has shown that the 
gene is upregulated linearly near the end of exponential phase, and rapidly declines in the 
early stationary growth phase (101). In relation to our murine nasopharyngeal infection, 
the precise interval when prtF2 is being transcribed is currently unknown and may occur 
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between 24 and 48 hours. To clarify this scenario, a more thorough in vivo time course 
should be performed, one that closely assesses the expression of FCT region genes, 
including transcription of the FBP-associated regulator msmR (137). Alternatively, cNT 
homogenates can be processed to extract cell surface-linked proteins, including PrtF2, from 
the bacteria; afterwards, the suspension can be used for immunoblotting against 
biotinylated fibronectin in order to visualize the presence of translated PrtF2 during an in 
vivo infection model (179).  
 
Collectively, our in vivo qRT-PCR analysis reveals that Cpa might be integral during the 
early stages of pharyngeal infection, whereas the expression status of the pilus and PrtF2 
is still unclear. The detection of tee18.1 and prtF2 transcripts in vitro, however, imply that 
these genes may be temporally or spatially regulated. Moving forward, we resolved to 
measure the bacterial burden of S. pyogenes during a murine nasopharyngeal infection and 
anticipated that the ΔFCT mutant would exhibit an attenuated infection phenotype. Using 
this model, we did not observe lower bacterial counts following inoculation with the ΔFCT 
mutant, clearly indicating that the FCT region is not essential for MGAS8232 pharyngeal 
infection (Figure 11).  
 
The genetic diversity of the FCT region likely helps aid S. pyogenes in its quest to infect 
and colonize humans successfully. In spite of the genomic diversity, however, the pilus 
may hold the potential for therapeutic developments. Naturally, since pili are relatively 
exposed on the bacterial surface, various pilus components are being examined as potential 
vaccine candidates, the most prominent of which being the major pilus subunit due to its 
strong immunogenicity (180). This area of research is still quite new and is complicated by 
the fact that the tee gene has massive diversity between S. pyogenes strains. Still, the 
protection conferred by the major pilus subunit is comparable to the protection conferred 
by the M protein in mice, yet there is significantly more genetic variation within the emm 
gene compared to the tee gene (47). One vaccination-based study used Lactococcus lactis 
recombinantly expressing S. pyogenes pili as a vector in order to stimulate a protective 
response against S. pyogenes bacterial challenge (176). Specifically, antibodies raised 
against MGAS8232 pili that were expressed on L. lactis inhibited adhesion by S. pyogenes 
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to skin in rabbits, while mice subjected to intranasal immunization were protected against 
nasopharyngeal infection (176). Even accounting for the diversity in tee, estimates suggest 
that a pilus-based vaccine that incorporates protective epitopes from twelve of the most 
common major pilus subunits would confer protection against >90% of S. pyogenes strains 
in the United States of America and the European Union (76).  
 
S. pyogenes remains a significant burden on human health, and developing a thorough 
understanding of its asymptomatic and pathogenic life cycle is vital to prevent and treat 
complications of infection. The FCT region is a highly recombinatorial locus within the 
genome of all S. pyogenes strains, and encodes numerous genes that may contribute to 
tissue tropism as well as the propensity to cause invasive disease. In this study, we 
characterized the binding capacity of S. pyogenes to collagen type IV and fibronectin and 
determined that the FCT region is indeed pertinent to binding these ECM proteins. We 
additionally characterized the adherence and invasion capabilities to pharyngeal tissue and 
have demonstrated that adhesion is not influenced by the FCT region, whereas invasion is 
greatly dependent on its presence. Finally, our work suggests that although the FCT region 
is not required to establish nasopharyngeal infection in mice, thereby nullifying our 
hypothesis, we provide transcriptional evidence that cpa may have a minor role during the 
early stages of pharyngeal infection. To conclude, further exploration of this diverse 
genomic locus holds the potential to comprehensively evaluate the life cycle of S. 
pyogenes, which in turn can provide insight on how to combat this globally-prevalent 
pathogen. 
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Appendix II. Detection of FCT region genes in mice infected with the MGAS8232 
ΔFCT mutant, a representation of zero/undetectable transcription. 
Transgenic mice (n = 4) expressing HLA-DR4/DQ8 were inoculated with 1×108 CFUs of 
the S. pyogenes MGAS8232 ΔFCT mutant and sacrificed 48 hours later. Their complete 
nasal turbinates were then harvested and processed for RNA extraction. qRT-PCR was then 
used to measure the mRNA transcription levels of cpa, tee18.1, and prtF2 in these mice 
normalized to the housekeeping gene gyrA. Bars represent the mean ± SEM of 4 mice 
analyzed using triplicate values. 
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Appendix III. Expression of cpa during murine nasopharyngeal infections 24 and 48 
hours post-inoculation. 
Transgenic mice expressing HLA-DR4/DQ8 were inoculated with 1×108 CFUs of wildtype 
S. pyogenes MGAS8232 and sacrificed 24 (n = 4) or 48 (n = 5) hours later. Their cNTs 
were harvested and processed for RNA extraction. qRT-PCR was then used to measure the 
mRNA transcription levels of cpa in these mice normalized to the housekeeping gene gyrA. 
Bars represent the mean ± SEM; statistical differences were evaluated using the unpaired 
t-test, (**p<0.01). 
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